Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer

被引：0
|
作者：
Colette A. Whitney
Lauren E. Howard
Stephen J. Freedland
Amanda M. DeHoedt
Christopher L. Amling
William J. Aronson
Matthew R. Cooperberg
Christopher J. Kane
Martha K. Terris
Timothy J. Daskivich
机构：
[1] Durham Veterans Affairs Medical Center,Division of Urology
[2] Duke University School of Medicine,Department of Biostatistics and Bioinformatics
[3] Cedars-Sinai Medical Center,Division of Urology
[4] Oregon Health Sciences University,Department of Urology
[5] West Los Angeles Veterans Affairs Medical Center,Division of Urology
[6] University of California,Department of Urology
[7] University of California,Department of Urology
[8] Charlie Norwood Veterans Affairs Medical Center,Division of Urology
[9] Medical College of Georgia,Division of Urology
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：252 / 260
页数：8
相关论文
共 50 条
  • [31] Re: Enzalutamide and Survival in Non-metastatic Castration-resistant Prostate Cancer
    Bagguley, Dominic
    Ong, Sean
    Lawrentschuk, Nathan
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2021, 79 (02) : 320 - 321
  • [32] Physician preferences for non-metastatic castration-resistant prostate cancer treatment
    Sandy Srinivas
    Ateesha F. Mohamed
    Sreevalsa Appukkuttan
    Marc Botteman
    Xinyi Ng
    Namita Joshi
    Erica Horodniceanu
    A. Reginald Waldeck
    Stacey J Simmons
    BMC Urology, 20
  • [33] Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide
    Gul, Anita
    Garcia, Jorge A.
    Barata, Pedro C.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7253 - 7262
  • [34] Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
    Small, E. J.
    Saad, F.
    Chowdhury, S.
    Oudard, S.
    Hadaschik, B. A.
    Graff, J. N.
    Olmos, D.
    Mainwaring, P. N.
    Lee, J. Y.
    Uemura, H.
    De Porre, P.
    Smith, A. A.
    Zhang, K.
    Lopez-Gitlitz, A.
    Smith, M. R.
    ANNALS OF ONCOLOGY, 2019, 30 (11) : 1813 - 1820
  • [35] Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management
    Tartarone, Alfredo
    Lerose, Rosa
    Tartarone, Marina
    MEDICAL ONCOLOGY, 2022, 39 (07)
  • [36] Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone
    Conteduca, Vincenza
    Caffo, Orazio
    Lolli, Cristian
    Aieta, Michele
    Scarpi, Emanuela
    Bianchi, Emanuela
    Maines, Francesca
    Schepisi, Giuseppe
    Salvi, Samanta
    Massari, Francesco
    Carrozza, Francesco
    Veccia, Antonello
    Chiuri, Vincenzo E.
    Campadelli, Enrico
    Facchini, Gaetano
    De Giorgi, Ugo
    PROSTATE, 2017, 77 (09): : 1012 - 1019
  • [37] Effect of fulvestrant on PSA doubling time in patients with castration-resistant prostate cancer (CRPC)
    Srinivas, S.
    Harshman, L. C.
    Feldman, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?
    Zachary Klaassen
    Lauren Howard
    Christopher J. D. Wallis
    Jessica L. Janes
    Amanda De Hoedt
    William J. Aronson
    Thomas J. Polascik
    Christopher J. Amling
    Christopher J. Kane
    Matthew R. Cooperberg
    Martha K. Terris
    Yuan Wu
    Stephen J. Freedland
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 151 - 155
  • [39] ASSOCIATION OF PROSTATE-SPECIFIC ANTIGEN TRAJECTORIES WITH MORTALITY IN VETERANS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Freedland, Stephen
    Young-Xu, Yinong
    Li, Sophia
    Pilon, Dominic
    Bhak, Rachel
    Duchesneau, Emilie
    Hellstern, Michael
    Behl, Ajay
    Lefebvre, Patrick
    Fuld, Alexander
    JOURNAL OF UROLOGY, 2019, 201 (04): : E497 - E498
  • [40] PSA MONITORING AND RESULTS AMONG MEN WITH NON-METASTATIC PROSTATE CANCER
    Wilson, K. L.
    Foley, K. A.
    VALUE IN HEALTH, 2014, 17 (03) : A96 - A96
12345